These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 11083629)

  • 1. Persistence of Chlamydia trachomatis is induced by ciprofloxacin and ofloxacin in vitro.
    Dreses-Werringloer U; Padubrin I; Jürgens-Saathoff B; Hudson AP; Zeidler H; Köhler L
    Antimicrob Agents Chemother; 2000 Dec; 44(12):3288-97. PubMed ID: 11083629
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Evaluation of in vitro activity of ofloxacin against 73 strains of Chlamydia trachomatis isolated from gynecologic infections].
    Catalan F; Milovanovic A; Prouteau C; Soulignac M
    Pathol Biol (Paris); 1998 Feb; 46(2):144-6. PubMed ID: 9769927
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro activities of ofloxacin and four other new quinoline-carboxylic acids against Chlamydia trachomatis.
    Nagayama A; Nakao T; Taen H
    Antimicrob Agents Chemother; 1988 Nov; 32(11):1735-7. PubMed ID: 3150916
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro activity of rufloxacin against Listeria monocytogenes, Legionella pneumophila, and Chlamydia trachomatis.
    Furneri PM; Bazzano M; Campo L; Cesana M; Tempera G
    Chemotherapy; 1994; 40(2):104-8. PubMed ID: 8131632
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of azithromycin and rifampin on Chlamydia trachomatis infection in vitro.
    Dreses-Werringloer U; Padubrin I; Zeidler H; Köhler L
    Antimicrob Agents Chemother; 2001 Nov; 45(11):3001-8. PubMed ID: 11600348
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chlamydia trachomatis: in vitro susceptibility of genital and ocular isolates to some quinolones, amoxicillin and azithromycin.
    Børsum T; Dannevig L; Størvold G; Melby K
    Chemotherapy; 1990; 36(6):407-15. PubMed ID: 1963393
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of sustained antibiotic bactericidal treatment on Chlamydia trachomatis-infected epithelial-like cells (HeLa) and monocyte-like cells (THP-1 and U-937).
    Mpiga P; Ravaoarinoro M
    Int J Antimicrob Agents; 2006 Apr; 27(4):316-24. PubMed ID: 16527461
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro activities of tetracycline & ciprofloxacin against Chlamydia trachomatis isolates from conjunctivitis patients.
    Madhavan HN; Roy S; Malathy J
    Indian J Med Res; 1996 Mar; 103():138-41. PubMed ID: 9062038
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of quinolones in chlamydial infection.
    Oriel JD
    Rev Infect Dis; 1989; 11 Suppl 5():S1273-6. PubMed ID: 2672254
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro activity of lomefloxacin (SC 47111 or NY-198) against Chlamydia trachomatis strains.
    Segreti J; Kessler HA; Kapell K; Trenholme GM
    Diagn Microbiol Infect Dis; 1989; 12(3 Suppl):87S-88S. PubMed ID: 2791503
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Comparative study of minimal inhibiting concentrations of doxycycline, ofloxacin and erythromycin against 18 recent isolates from Chlamydia trachomatis (1994-1995)].
    Bianchi A; Legouge R; Lefevre JC; Askienazy-Elbhar M; Joly-Guillou ML; Pavis A; Sednaoui P
    Pathol Biol (Paris); 1996 May; 44(5):347-50. PubMed ID: 8758473
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [In vitro effectiveness of ofloxacin and ciprofloxacin in genital Chlamydia trachomatis isolates measured by minimal inhibitory concentration and minimal bactericidal concentration].
    Hartinger A; Korting HC; Neubert U; Blaufuss H
    Z Hautkr; 1988 Jan; 63(1):29-32. PubMed ID: 3162627
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro activity of the new difluorinated quinolone sparfloxacin (AT-4140) against Mycobacterium tuberculosis compared with activities of ofloxacin and ciprofloxacin.
    Rastogi N; Goh KS
    Antimicrob Agents Chemother; 1991 Sep; 35(9):1933-6. PubMed ID: 1952872
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of the in vitro activities of ofloxacin and tetracycline against Chlamydia trachomatis as assessed by indirect immunofluorescence.
    Bailey JM; Heppleston C; Richmond SJ
    Antimicrob Agents Chemother; 1984 Jul; 26(1):13-6. PubMed ID: 6383207
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro activities of five quinolones against Chlamydia pneumoniae.
    Hammerschlag MR; Hyman CL; Roblin PM
    Antimicrob Agents Chemother; 1992 Mar; 36(3):682-3. PubMed ID: 1320366
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In-vitro activity of gatifloxacin against Chlamydia trachomatis and Chlamydia pneumoniae.
    Roblin PM; Hammerschlag MR
    J Antimicrob Chemother; 1999 Oct; 44(4):549-51. PubMed ID: 10588319
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In-vitro activity of ofloxacin against Chlamydia trachomatis.
    Sambri V; Rumpianesi F; Xerri L; Cevenini R
    J Chemother; 1989 Aug; 1(4):231-2. PubMed ID: 2809689
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of ciprofloxacin and ofloxacin using human corneal susceptibility levels.
    Kowalski RP; Karenchak LM; Gordon YJ
    Cornea; 1998 May; 17(3):282-7. PubMed ID: 9603384
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro activities of rifamycin derivatives ABI-1648 (Rifalazil, KRM-1648), ABI-1657, and ABI-1131 against Chlamydia trachomatis and recent clinical isolates of Chlamydia pneumoniae.
    Roblin PM; Reznik T; Kutlin A; Hammerschlag MR
    Antimicrob Agents Chemother; 2003 Mar; 47(3):1135-6. PubMed ID: 12604555
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gatifloxacin and moxifloxacin: an in vitro susceptibility comparison to levofloxacin, ciprofloxacin, and ofloxacin using bacterial keratitis isolates.
    Kowalski RP; Dhaliwal DK; Karenchak LM; Romanowski EG; Mah FS; Ritterband DC; Gordon YJ
    Am J Ophthalmol; 2003 Sep; 136(3):500-5. PubMed ID: 12967804
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.